Literature DB >> 2210071

Heart-rate variability and cardiac autonomic function in diabetes.

S C Malpas1, T J Maling.   

Abstract

Cardiac autonomic function was measured in 25 subjects with insulin-dependent diabetes mellitus and 11 control subjects. Autonomic integrity was assessed with standard tests of autonomic function and a new technique of measuring heart-rate variability (HRV) for 24 h. All of the diabetic subjects were selected on the basis of peripheral or autonomic neuropathy or long-term poorly controlled diabetes. They were divided into groups according to presence or absence of vagal neuropathy based on the results of standard tests of autonomic function. Thirteen diabetic subjects had normal autonomic function tests (group 1), and vagal neuropathy was detected in 12 diabetic subjects (group 2). All subjects were monitored by ambulatory electrocardiograph, and the recordings were played back through an analyzer that identified and timed successive pulse (R-R) intervals. HRV was measured from the standard deviation of the successive differences between R-R intervals. HRV was significantly reduced in group 1 (mean +/- SE 73 +/- 9 ms) and group 2 (65 +/- 12 ms) diabetic subjects compared with the control group (138 +/- 10 ms). The standard tests of autonomic function did not distinguish the vagal dysfunction noted with HRV monitoring in group 1 diabetic subjects compared with control subjects. Measurement of 24-h HRV can detect small changes in cardiac autonomic function compared with currently available tests.

Entities:  

Mesh:

Year:  1990        PMID: 2210071     DOI: 10.2337/diab.39.10.1177

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  36 in total

Review 1.  The riddles of heart rate variability.

Authors:  J M Karemaker
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

2.  Autonomic control during acute hypoglycemia in type 1 diabetes mellitus.

Authors:  Jacqueline K Limberg; Kathryn E Farni; Jennifer L Taylor; Simmi Dube; Ananda Basu; Rita Basu; Erica A Wehrwein; Michael J Joyner
Journal:  Clin Auton Res       Date:  2014-09-27       Impact factor: 4.435

3.  Autonomic dysfunction is related to impaired pancreatic beta cell function in patients with coronary artery disease.

Authors:  J W Sayer; B Marchant; S V Gelding; J A Cooper; A D Timmis
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

4.  H2-blocker modulates heart rate variability.

Authors:  T Ooie; T Saikawa; M Hara; H Ono; M Seike; T Sakata
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

5.  Heart rate variability and outcome in acute severe stroke: role of power spectral analysis.

Authors:  Arunodaya R Gujjar; Talakad N Sathyaprabha; Dindagur Nagaraja; Kandavel Thennarasu; Nithyananda Pradhan
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Effect of hypoxia on heart rate variability and baroreflex sensitivity during hypoglycemia in type 1 diabetes mellitus.

Authors:  Jacqueline K Limberg; Simmi Dube; Myrthe Kuijpers; Kathryn E Farni; Ananda Basu; Robert A Rizza; Timothy B Curry; Rita Basu; Michael J Joyner
Journal:  Clin Auton Res       Date:  2015-07-04       Impact factor: 4.435

7.  Predictors of heart rate variability and its prognostic significance in chronic kidney disease.

Authors:  Preeti Chandra; Robin L Sands; Brenda W Gillespie; Nathan W Levin; Peter Kotanko; Margaret Kiser; Fredric Finkelstein; Alan Hinderliter; Rodica Pop-Busui; Sanjay Rajagopalan; Rajiv Saran
Journal:  Nephrol Dial Transplant       Date:  2011-09-12       Impact factor: 5.992

Review 8.  Time and frequency domain assessment of heart rate variability: a theoretical and clinical appreciation.

Authors:  J P Spiers; B Silke; U McDermott; R G Shanks; D W Harron
Journal:  Clin Auton Res       Date:  1993-04       Impact factor: 4.435

9.  Heart rate variability: short-term studies are as useful as holter to differentiate diabetic patients from healthy subjects.

Authors:  Eduardo R Migliaro; Paola Contreras
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

10.  Diabetes increases mortality after myocardial infarction by oxidizing CaMKII.

Authors:  Min Luo; Xiaoqun Guan; Elizabeth D Luczak; Di Lang; William Kutschke; Zhan Gao; Jinying Yang; Patric Glynn; Samuel Sossalla; Paari D Swaminathan; Robert M Weiss; Baoli Yang; Adam G Rokita; Lars S Maier; Igor R Efimov; Thomas J Hund; Mark E Anderson
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.